SMWB · Similarweb Ltd.

The thesis

Similarweb's pivot from web-traffic analytics to licensing its data for artificial intelligence (AI) is still unproven in reported revenue, and the shares now sit near their high ahead of two events that test it: the new chief executive's start on 2 November 2026 and the third-quarter report. The case is confirmed if Q3 revenue lands inside the $80.5–82.5 million guidance issued on 12 August 2026 and AI-related revenue exceeds the 13% share of Q2 sales.

The change since the 16 October 2026 note is price. The adjusted close was $9.10 on 28 October 2026, against $8.79 on 15 October 2026 and $7.96 on 2 October 2026. That is 2.0% below the $9.29 adjusted 52-week high. The 14-day relative strength index, a 0–100 momentum gauge, was 60.1 on 28 October 2026. Searches of company releases and news found no new results, guidance or contract disclosure since the 24 September 2026 CEO announcement, so the rebound has come without fresh revenue evidence.

The narrative is maturing: the August contract disclosures, the September analyst upgrades and the CEO change are all well known, and the next new evidence is the Q3 report.

Bullish and bearish views on Similarweb Ltd.

The bull case on Similarweb Ltd. (SMWB), in brief: Reported growth came with operating profit. The bear case: A founder-led company changes chief executive mid-pivot.

Bull case

• Reported growth came with operating profit. The 12 August 2026 Q2 release showed revenue of $77.2 million, up 9% from a year earlier, and GAAP operating profit of $0.7 million. Management raised 2026 revenue guidance to $314–318 million from $307–315 million.
• AI licensing has disclosed contract value. The same release cited three multi-year AI contracts with about $60 million of total contract value. AI-related revenue was 13% of Q2 sales.
• Guidance sits above analyst estimates. Benzinga reported on 12 August 2026 that Q3 guidance of $80.5–82.5 million compared with a $78.825 million analyst estimate. Full-year guidance compared with a $310.241 million estimate.
• Sell-side targets sit at or above the share price. Needham's Scott Berg upgraded the shares and set an $11 target on 16 September 2026, per Benzinga. Barclays set $11 and Northland $10 in August. Citigroup, rated Neutral, set $9 on 13 August 2026, and Oppenheimer set $8.50 on 5 August 2026. The $9.10 close is above both of those targets.
• The incoming CEO comes from data and advertising. The 24 September 2026 announcement said Michael Akkerman held senior roles at data.ai, Cardlytics, Uber and Pinterest, and that the company's strategy and outlook are unchanged.

Bear case

• A founder-led company changes chief executive mid-pivot. Akkerman starts on 2 November 2026, succeeding founder Or Offer, shortly before the expected Q3 report. BigGo Finance reported the shares fell more than 7% on the 24 September 2026 announcement.
• Customer expansion is flat. Net revenue retention was 100% at 30 June 2026, per the 12 August 2026 results. Existing customers were not spending more in aggregate.
• Insiders sold into strength. A Form 4 filed 27 August 2026 showed Offer selling 383,127 ordinary shares after option exercises.
• Partnership revenue is unquantified. The 2 September 2026 collaboration with NIQ promised initial availability in Q4 2026 with no disclosed contract value.
• The price already sits near the high. The shares gained 26.9% over three months to 28 October 2026 and closed 2.0% below the 52-week high. Two of three sell-side targets cited above (Citigroup's $9 and Oppenheimer's $8.50) are now below the close.

Price setup

The adjusted close of $9.10 on 28 October 2026 is 2.0% below the $9.29 adjusted 52-week high. The close of $7.96 on 2 October 2026 is the recent low and marks the early-October low area. The relative strength index fell from 68.8 on 15 October 2026 to 60.1 on 28 October 2026 while the price rose, so the advance has continued with less momentum than two weeks earlier.

A close above $9.29 would set a new 52-week high. A close below $7.96 would erase the whole rebound since 2 October 2026. The $7.50 level used for invalidation sits below that October low.

Crowding evidence is limited to the three-month gain, the proximity to the high and an earnings date within weeks. No new Form 4 or Form 144 insider sales or share-offering notices were found after the 27 August 2026 filing.

Catalysts, next 30 days

• 2 November 2026: Michael Akkerman becomes chief executive. Any change to strategy, guidance or senior staff around the handover would bear on the AI-licensing plan.
• ~12 November 2026 (est.): Q3 2026 results. The estimate follows last year's pattern, when Q3 2025 results came on 11 November 2025; the company has not confirmed a date in anything found. The report shows whether revenue lands within $80.5–82.5 million and whether AI-related revenue exceeds 13% of sales.
• Q4 2026 (no date): Initial availability of the NIQ collaboration, which the company has not tied to a contract value.

What would change the view

The case breaks if Q3 revenue prints below the $80.5 million low end of guidance, or if guidance is withdrawn or lowered around the CEO handover. It also breaks if AI-related revenue falls to 13% of sales or less with no new multi-year contract disclosed.

On price, a daily close below $7.50 would take the shares under the early-October low area and erase the rebound since 2 October 2026. A confirmed Q3 beat with AI revenue above 13% of sales would strengthen the case; one report would not settle whether licensing is recurring.

What it trades with

Similarweb sells subscription analytics to marketers and enterprises and is now seeking AI-related licensing revenue, so it trades with small and mid-cap software shares and with sentiment on AI data suppliers. It is an Israeli company listed on the NYSE and reports on foreign-issuer forms. Its sensitivity to AI sentiment has come through contract announcements and analyst actions rather than through reported AI revenue, which was 13% of Q2 sales.